Literature DB >> 26719964

Residual Cholesteatoma After Endoscope-guided Surgery in Children.

Adrian L James1, Sharon Cushing, Blake C Papsin.   

Abstract

OBJECTIVE: Endoscopes can facilitate surgery within tympanomastoid recesses that are not visible with the operating microscope. This study investigates whether use of endoscopes to guide dissection of cholesteatoma leads to lower rates of residual cholesteatoma than using the endoscope only for inspection after microscope-guided dissection. STUDY
DESIGN: Comparative cohort study.
SETTING: Tertiary pediatric center. PATIENTS: Two hundred thirty-five patients with acquired or congenital cholesteatoma in children <18 years having intact canal wall surgery and follow-up >12 months.
INTERVENTIONS: Comparison of group (A) microscope surgery followed by endoscopic inspection, with group (B) endoscope-guided dissection. MAIN OUTCOME MEASURES: Residual cholesteatoma rates, controlling for site of initial cholesteatoma, detection by second-stage surgery, and length of follow-up.
RESULTS: Analysis of all patients showed endoscopic dissection was associated with less residua in the middle ear (risk difference = 0.12; p = 0.026, Kaplan-Meier log rank analysis; number needed to treat = 9) but not at other sites. When restricting analysis to ears that were evaluated with second look surgery, no significant reduction in residual disease was found after endoscopic dissection at any site (e.g., retrotympanic residua: 12% Group A versus 7% Group B (NS, Fisher exact test). Endoscopic dissection allowed more permeatal surgery. No complications were attributable to endoscope use. Wound complications occurred in 4% of open cases.
CONCLUSION: Endoscopes enhance surgical access to tympanomastoid recesses. In conjunction with the availability of the operating microscope, angled instruments, and KTP laser, endoscope-guided dissection provides a small incremental benefit for prevention of residual cholesteatoma, and facilitates a minimally invasive approach.

Entities:  

Mesh:

Year:  2016        PMID: 26719964     DOI: 10.1097/MAO.0000000000000948

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  The variants of the retro- and hypotympanum: an endoscopic anatomical study.

Authors:  Marco Bonali; Lukas Anschuetz; Matteo Fermi; Domenico Villari; Giulia Adalgisa Mariani; Lucia Manzoli; Marco Caversaccio; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-27       Impact factor: 2.503

2.  Evaluation of Residual Disease Following Transcanal Totally Endoscopic vs Postauricular Surgery Among Children With Middle Ear and Attic Cholesteatoma.

Authors:  Peter R Dixon; Adrian L James
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

3.  Variability of the retrotympanum and its association with mastoid pneumatization in cholesteatoma patients.

Authors:  Franca Wagner; Lukas Anschuetz; Sara-Lynn Hool; Sven Beckmann; Arsany Hakim; Abraam Yacoub; Marco Caversaccio
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-13       Impact factor: 2.503

4.  Endoscopic-Assisted Canal Wall-up Tympanomastoidectomy for Reduction of Residual Cholesteatoma.

Authors:  Mauricio Noschang Lopes Silva; Fábio André Selaimen; Felipe da Costa Huve; Fernanda Dias Toshiaki Koga; Luciana Lima Martins-Costa; João Augusto Polesi Bergamaschi; Alice Lang Silva; Sady Selaimen da Costa
Journal:  Int Arch Otorhinolaryngol       Date:  2021-10-19

5.  Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma.

Authors:  Joo Hyun Park; Jungmin Ahn; Il Joon Moon
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-06-27       Impact factor: 3.372

6.  Extending otology services to rural settings: Value of endoscopic ear surgery.

Authors:  Abubakar Danjuma Salisu; Yasir Nuhu Jibril
Journal:  Ann Afr Med       Date:  2016 Jul-Sep

7.  Label-free visualization of cholesteatoma in the mastoid and tympanic membrane using CARS microscopy.

Authors:  Jing Zou; Antti Isomäki; Timo Hirvonen; Antti Aarnisalo; Jussi Jero; Ilmari Pyykkö
Journal:  J Otol       Date:  2016-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.